NPPA fixes retail prices of 23 formulations

Published On 2022-04-14 11:48 GMT | Update On 2023-10-06 11:26 GMT

New Delhi: National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of India has fixed retail prices of 23 formulations under Drugs (Prices Control) Order, 2013.The authority has fixed the retail prices based on the decision of 96th Authority meeting dated 24.03.2022.The formulations include Mascot Health Series Pvt. Ltd. and Zydus Healthcare...

New Delhi: National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of India has fixed retail prices of 23 formulations under Drugs (Prices Control) Order, 2013.

The authority has fixed the retail prices based on the decision of 96th Authority meeting dated 24.03.2022.

The formulations include Mascot Health Series Pvt. Ltd. and Zydus Healthcare Ltd.'s Levetiracetam Tablet, Sterling Labs and Micro Labs Limited's Paracetamol Bilayer Tablets, Pure & Cure Healthcare Pvt. Ltd. and Dr. Reddy's Laboratories Limited 's Paracetamol, Phenylephrine Hydrochloride, Caffeine and Diphenhydramine Hydrochloride tablet.

The list also include Akums Drugs & Pharmaceuticals Ltd. and M/s Abbott Healthcare Pvt. Ltd.'s Cefixime, Cloxacillin & Lactic Acid Bacillus Tablets, Ravenbhel Healthcare Pvt. Ltd. and Lupin's Gliclazide ER plus Metformin ER Tablet.

This comes after in exercise of the powers conferred by paragraphs 5, 11 and 15 of the Drugs (Prices Control) Order, 2013, read with S.O. 1394(E) dated the 30th May, 2013 and S. O. 701(E) dated 10th March, 2016 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority (hereinafter referred as NPPA), hereby fixes, the price as specified in column (6) of the table herein below as the retail price, exclusive of Goods and Services Tax, if any, in relation to the formulation specified in the corresponding entry in column (2) of the said Table with the strength, unit and name of manufacturer & marketing company, as specified in the corresponding entries in columns (3), (4) and (5) thereof;

Sl. No .	Name of the Formulation / Brand Name	Strength	Unit	Manufacturer & Marketing Company	Retail Price (Rs.)
(1)	(2)	(3)	(4)	(5)	(6)
1.	Telmisartan + Cilnidipine + Chlorthalidone Tablet	Each film coated tablet contains: Telmisartan IP 40 mg Cilnidipine IP 10 mg Chlorthalidone IP 6.25 mg	1 Tablet	M/s Unison Pharmaceuticals Pvt. Ltd.	11.61
2.	Paracetamol Bilayer Tablets 1000 mg	Each uncoated bilayered tablet contains: Paracetamol IP 300 mg (as immediate release) Paracetamol IP 700 mg (as sustained release)	1 Tablet	M/s Sterling Labs / M/s Micro Labs Limited	4.07
3.	Levetiracetam Tablet	Each film coated tablet contains: Levetiracetam IP 1000 mg	1 Tablet	M/s Mascot Health Series Pvt. Ltd. / M/s Zydus Healthcare Ltd.	30.38
4.	Torsemide and Spironolactone Tablets	Each film coated tablet contains: Torsemide IP 10mg	1 Tablet	M/s Mascot Health Series Pvt. Ltd. / M/s J.	2.71
		Spironolactone IP 25mg		B. Chemicals & Pharmaceuticals Limited
5.	Paracetamol, Phenylephrine Hydrochloride, Caffeine and Diphenhydramine Hydrochloride tablet	Each film coated tablet contains: Paracetamol IP 500mg Phenylephrine Hydrochloride IP 5mg Caffeine (anhydrous) IP 30mg Diphenhydramine Hydrochloride IP 25mg	1 Tablet	M/s Pure & Cure Healthcare Pvt. Ltd. / Dr. Reddy's Laboratories Limited	3.21
6.	Metformin Hydrochloride (as Prolonged- Release)+ Glimepiride Tablet IP	Each Uncoated bilayered tablet contains: Metformin Hydrochloride IP 500mg (as Prolonged- Release) Glimepiride IP 2mg	1 Tablet	M/s East African (India) Overseas / M/s La-Medica Life Sciences Pvt. Ltd.	8.24
7.	Metformin Hydrochloride (as Prolonged- Release)+ Glimepiride Tablet IP	Each uncoated bilayered tablet contains: Metformin Hydrochloride IP 500mg (as Prolonged- Release) Glimepiride IP 1mg	1 Tablet	M/s East African (India) Overseas / M/s La-Medica Life Sciences Pvt. Ltd.	5.63
8.	Cefixime, Cloxacillin & Lactic Acid Bacillus Tablets	Each film coated tablet contains: Cefixime IP as Trihydrate eq. to Anhydrous Cefixime 200mg, Cloxacillin Sodium IP eq. to Cloxacillin 500mg (in extended release form), Lactic Acid Bacillus 90 Million Spores.	1 Tablet	M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Abbott Healthcare Pvt. Ltd.	14.65
9.	Diclofenac Transdermal Patch	Each 75Sq cm Transdermal Patch contains: Diclofenac Diethylamine IP 200mg	1 Patch	M/s Azista Industries Pvt. Ltd. / M/s Hetero Healthcare Ltd.	40.18
10.	Efonidipine Hydrochloride Ethanolate + Telmisartan Tablet	Each uncoated bilayered tablet contains: Efonidipine Hydrochloride Ethanolate 20mg, Telmisartan IP 40mg	1Tablet	M/s Zuventus Healthcare Limited	9.94
11.	Gliclazide ER + Metformin ER Tablet	Each uncoated bilayered tablet contains: Gliclazide IP (as extended release form) 60mg Metformin Hydrochloride IP (as extended release form) 1000mg	1 Tablet	M/s Ravenbhel Healthcare Pvt. Ltd. / M/s Lupin Limited	8.53
12.	Bisoprolol Fumarate & Amlodipine tablet	Each film coated tablet contains: Bisoprolol Fumarate IP 5mg Amlodipine Besylate IP Eq. to Amlodipine 5mg	1 Tablet	M/s Swiss Garnier Biotech Ltd. / Dr. Reddy's Laboratories Limited	6.69
13.	Bisoprolol Fumarate & Amlodipine tablet	Each film coated tablet contains: Bisoprolol Fumarate IP 2.5mg Amlodipine Besylate IP Eq. to Amlodipine 5mg	1 Tablet	M/s Swiss Garnier Biotech Ltd. / Dr. Reddy's Laboratories Limited	4.46
14.	Paracetamol & Mefenamic Acid tablet	Each Uncoated Tablet contains: Paracetamol IP 325mg Mefenamic Acid IP 500mg	1 Tablet	M/s Mascot Health Series Pvt. Ltd. / M/s Alkem Laboratories Limited	3.27
15.	Levofloxacin Infusion IP (0.5% w/v)	Each 100 ml contains: Levofloxacin Hemihydrate IP eq. to Levofloxacin 500 mg Sodium Chloride IP 900 mg , Water for Injection IP q. s.	1 ml	M/s Akums Drugs & Pharmaceuticals Ltd./M/s Emcure Pharmaceuticals Ltd.	1.32
16.	Paracetamol & Tramadol HCl tablet USP	Each uncoated Tablet contains: Paracetamol IP 325mg Tramadol HCL IP 37.5mg	1 Tablet	M/s Mascot Health Series Pvt. Ltd. / M/s Hetero Healthcare Ltd.	8.35
17.	Ceftriaxone & Tazobactam for Injection 1125mg	Each vial contains: Sterile Ceftriaxone Sodium IP eq. to Ceftriaxone 1000mg Sterile Tazobactam Sodium IP eq. to Tazobactam 125mg Each ampoule contains: 10ml Sterile water for Injection IP	1 Vial	M/s Prosperity Six Pharmaceuticals / M/s Torrent Pharmaceuticals Limited	167.87
18.	Telmisartan + Cilnidipine + Chlorthalidone Tablet	Each film coated tablet contains: Telmisartan IP 40 mg + Cilnidipine IP 10 mg + Chlorthalidone IP 12.50 mg	1 Tablet	M/s Unison Pharmaceuticals Pvt. Ltd.	12.94
19.	Amoxycillin + Potassium Clavulanate Oral Suspension	Each ml of constituted suspension contains: Amoxycillin Trihydrate IP eq. to Amoxycillin 80mg Potassium Clavulanate Diluted IP eq. to Clavulanic Acid 11.4mg	1 ml	M/s Copmed Pharmaceuticals Pvt. Ltd. / M/s Mankind Prime Labs Pvt. Ltd.	7.42
20.	Tramadol HCl + Acetaminophen (Paracetamol)Ta blet	Each uncoated tablet contains: Tramadol HCl 37.5mg Acetaminophen (Paracetamol) 325mg	1 Tablet	M/s Penta Kraft / M/s Mankind Prime Labs Pvt. Ltd.	8.35
21.	Clonazepam mouth dissolving Tablet	Each uncoated mouth dissolving tablet contains: Clonazepam IP 2mg	1 Tablet	M/s Lifecare Neuro Products Ltd./ M/s Mankind Pharma Ltd.	8.60
22.	Cefixime, Dicloxacillin MR & Lactic Acid Bacillus Tablets	Each modified release tablet contains: Cefixime IP as Trihydrate eq. to Anhydrous Cefixime 200mg (in immediate release form), Dicloxacillin Sodium IP eq. to Dicloxacillin 500mg (in modified release form), Lactic Acid Bacillus 2.5 Billion Spores.	1 Tablet	M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Abbott Healthcare Pvt. Ltd.	18.24
23.	Efonidipine Hydrochloride Ethanolate + Telmisartan Tablet	Each uncoated bilayered tablet contains: Efonidipine Hydrochloride Ethanolate 40mg, Telmisartan IP 40mg	1 Tablet	M/s Zuventus Healthcare Limited	15.67

(a) The manufacturer of above mentioned formulations i.e. "new drug" under paragraph 2(u) of the DPCO, 2013 shall fix the retail price as specified in column (6) of the table hereinabove.

(b) The manufacturer may add Goods and Services Tax only if they have paid actually or it is payable to the Government on the retail price mentioned in column (6) of the above said table.

(c) The retail price for a pack of the aforesaid formulation shall be arrived at by the concerned manufacturer in accordance with the retail price specified in column (6) of the above table as per provisions contained in paragraph 11 of the DPCO, 2013. The manufacturer shall issue a price list in Form–V from date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State Drug Controller and dealers.

(d) As per para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business in a manner so as to be easily accessible to any person wishing to consult the same.

(e) The above mentioned retail price is applicable only to the individual manufacturer / marketer as mentioned above i.e. who have applied for the same by submitting Form-I for price fixation / revision as stipulated under DPCO, 2013 and subject to fulfilment of all the applicable statutory requirements as laid down by the Govt. under relevant statutes/ rules, including manufacturing license permission from the Competent Authority i.e. the Central/State Licensing Authority, as may be applicable, by the concerned manufacturer/marketing companies.

(f) In case the retail price of any of the aforesaid formulations is not complied with, as per instant price notification and notes specified hereinabove, then the concerned manufacturer/marketing company shall be liable to deposit the overcharged amount along with the interest thereon under the provisions of the DPCO, 2013 read with the Essential Commodities Act, 1955.

(g) Consequent to the issue of ceiling price of such formulation as specified in column (2) of the above table in this notification, the price order(s) fixing ceiling or retail price, if any, issued prior to the above said date of notification, stand(s) superseded.

For more details, read the full notice by clicking on the link below:

https://medicaldialogues.in/pdf_upload/23-formulations-222111.pdf

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Desk Editor for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

NPPA fixes retail prices of 23 formulations

Similar News